Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Annals of Neurology|July 29, 2025
Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability AssociationsAmy Kunchok, Moein Amin, Tatchaporn Ongphichetmetha, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 8, 2024
High-resolution diffusion tensor imaging of the fornix predicts memory function in multiple sclerosisKatherine A Koenig, Ken E Sakaie, Daniel Ontaneda, et al.
Neurology|July 1, 2021
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple SclerosisKarla Gray-Roncal, Kathryn C Fitzgerald, Lana Zhovtis Ryerson, et al.
Neurology|January 24, 2024
Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor EncephalitisAnnalisa Morgan, Yadi Li, Nicolas R Thompson, et al.
Annals of Clinical and Translational Neurology|January 22, 2024
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disordersSanem P Uysal, Yadi Li, Nicolas R Thompson, et al.
Journal of the Neurological Sciences|October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-upBrandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Neurology. Clinical Practice|July 10, 2020
Achieving effective patient and public involvement in international clinical trials in neurologyEmma C Tallantyre, Nikos Evangelou, Clare Bale, et al.
AJNR. American Journal of Neuroradiology|March 13, 2026
Superior visibility of paramagnetic rim lesions on filtered phase versus SWIJoshua D Lee, Brian Renner, Sreekanth Madhusoodhanan Nair, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2024
A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosisXiaotong Jiang, Marisa McGinley, Joshua Johnston, et al.
Multiple Sclerosis and Related Disorders|May 27, 2021
Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating diseaseGabrielle Macaron, Jean Khoury, Rula A Hajj-Ali, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Annals of Neurology|July 29, 2025
Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability AssociationsAmy Kunchok, Moein Amin, Tatchaporn Ongphichetmetha, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 8, 2024
High-resolution diffusion tensor imaging of the fornix predicts memory function in multiple sclerosisKatherine A Koenig, Ken E Sakaie, Daniel Ontaneda, et al.
Neurology|July 1, 2021
Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple SclerosisKarla Gray-Roncal, Kathryn C Fitzgerald, Lana Zhovtis Ryerson, et al.
Neurology|January 24, 2024
Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor EncephalitisAnnalisa Morgan, Yadi Li, Nicolas R Thompson, et al.
Annals of Clinical and Translational Neurology|January 22, 2024
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disordersSanem P Uysal, Yadi Li, Nicolas R Thompson, et al.
Journal of the Neurological Sciences|October 24, 2019
Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-upBrandi Vollmer, Daniel Ontaneda, Haleigh Harris, et al.
Neurology. Clinical Practice|July 10, 2020
Achieving effective patient and public involvement in international clinical trials in neurologyEmma C Tallantyre, Nikos Evangelou, Clare Bale, et al.
AJNR. American Journal of Neuroradiology|March 13, 2026
Superior visibility of paramagnetic rim lesions on filtered phase versus SWIJoshua D Lee, Brian Renner, Sreekanth Madhusoodhanan Nair, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2024
A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosisXiaotong Jiang, Marisa McGinley, Joshua Johnston, et al.
Multiple Sclerosis and Related Disorders|May 27, 2021
Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating diseaseGabrielle Macaron, Jean Khoury, Rula A Hajj-Ali, et al.
Pageof 20